Sarah Bigelow was named executive director of the Clinical Trials Office at the Tulane Cancer Center.
Jozef Madzo was named director of bioinformatics at the Wistar Institute. He will lead and oversee Wistar’s bioinformatics projects and initiatives across a variety of advanced biomedical research programs.
Sonal Paul joined the George Washington University Cancer Center and the GW Medical Faculty Associates as a hematologist-oncologist specializing in gastrointestinal cancers.
The University of Arkansas for Medical Sciences College of Pharmacy invested Marjan Boerma, director of the UAMS College of Pharmacy Division of Radiation Health and associate director of basic science in the UAMS Winthrop P. Rockefeller Cancer Institute, in the J. Thomas May Distinguished Endowed Chair in Oncology in a June 25 ceremony.
The University of Texas MD Anderson Cancer Center and Rice University formed the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis, and treatment.
The Snyder estate, now being sold by ACS. Source: Google, ©2024 AirbusThe American Cancer Society is selling the 25,000 square-foot mansion that was donated to the society by former Washington Commanders owner Dan Snyder and his wife Tanya Snyder, a breast cancer survivor, in March (The Cancer Letter, March 29, 2024).
Vivek S. Kavadi was named CEO of the American Society for Radiation Oncology. He will succeed Laura Thevenot, who has led the organization since 2002.
Miguel Villalona Calero was named deputy director of the University of California, Irvine Chao Family Comprehensive Cancer Center and division chief for hematology/oncology. He will start on July 8.
Zachary SteinhartMaxwell FoiseyDebolina GangulySean Yamada-HunterThe Parker Institute for Cancer Immunotherapy, a collaborative consortium of the world’s leading immuno-oncology experts, named its 2024 class of Early Career Researcher awardees.
The Wistar Institute’s Noam Auslander, assistant professor in the Molecular and Cellular Oncogenesis Program at the Ellen and Ronald Caplan Cancer Center, was awarded a $600,000 Women Scientists Innovation Award for Cancer Research grant from the V Foundation for Cancer Research.
